Patents by Inventor Gail McIntyre

Gail McIntyre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS
    Publication number: 20240009271
    Abstract: Compositions and methods are provided for treating a human metastatic cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL protein activity, for example by inhibition of the binding interaction between AXL and its ligand GAS6.
    Type: Application
    Filed: August 1, 2023
    Publication date: January 11, 2024
    Inventors: Gail McIntyre, David Prohaska, Ray Tabibiazar
  • DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS
    Publication number: 20230277631
    Abstract: The present invention provides therapeutic and diagnostic methods and compositions for treating a human metastatic cancer. Specifically, the invention provides methods of treatment and methods for determining whether an individual suffering from a cancer is responding to an AXL decoy protein-based therapy, predicting responsiveness of an individual suffering from a cancer to treatment comprising an AXL decoy protein, and methods of selecting a therapy for an individual suffering from cancer.
    Type: Application
    Filed: July 18, 2021
    Publication date: September 7, 2023
    Inventors: Gail McIntyre, Ray Tabibiazar, Elisabeth Gardiner
  • METHODS OF TREATING CLEAR CELL RENAL CELL CARCINOMA (ccRCC) USING AXL DECOY RECEPTORS
    Publication number: 20230084893
    Abstract: Compositions and methods are provided for treating advanced clear cell renal cell carcinoma (RCC) in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL protein activity, for example by inhibition of the binding interaction between AXL and its ligand GAS6, in combination with a therapeutic dose of cabozantinib.
    Type: Application
    Filed: January 5, 2021
    Publication date: March 16, 2023
    Inventors: Gail MCINTYRE, Laura BONIFACIO
  • METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS
    Publication number: 20200289613
    Abstract: Compositions and methods are provided for treating a human metastatic cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL protein activity, for example by inhibition of the binding interaction between AXL and its ligand GAS6.
    Type: Application
    Filed: November 5, 2018
    Publication date: September 17, 2020
    Inventors: Gail McIntyre, David Prohaska, Ray Tabibiazar